About Shanghai Medicilon Inc. Company

The company is a professional biomedical pre-clinical comprehensive research and development service CRO, providing a full range of one-stop new drug research and development services that meet domestic and international application standards for pharmaceutical companies and research institutions around the world. Drug discovery research and development service projects include chemical synthesis, compound activity screening and optimization, structural biology research, protein target verification, etc.; pharmaceutical research includes research on raw materials and formulation processes, quality standards and stability studies; and pre-clinical research includes pharmacodynamics, pharmacokinetics, and toxicological safety evaluation studies. The company's main business is to provide pharmaceutical research and development services for drug discovery, pharmaceutical research, and pre-clinical research to pharmaceutical companies and research institutes through R&D technology platforms. The company's services cover the whole process of pre-clinical drug research, mainly including drug discovery, pharmaceutical research and pre-clinical research. Drug discovery R&D service projects include protein target verification, structural biology, chemical synthesis, and compound activity screening and optimization; pharmaceutical research includes research on raw materials and formulation processes, quality standards and stability studies; and pre-clinical research includes pharmacodynamics, pharmacokinetics, and toxicological safety evaluation studies. Corporate honors: The company won the “2023 Top 20 Chinese Pharmaceutical CRO Companies”, etc. “2023 China Biomedical Industry Value List 'Top 10 Most Influential CRO Enterprises'”, “China's Top 50 Pharmaceutical Research and Development Awards”, “2023 Jinniu Science and Technology Innovation Award”, the company was awarded the “4th Pharmaceutical Innovation Award”, “2024VBEF 'Best Pharmaceutical Customer Satisfaction Pharmaceutical CRO'”, “BIOCHINA '2023 Supplier of the Year'”, “Top Ten Innovative Biotechnology Enterprises in 2024”, “2024 Top Ten Innovative Biotech Companies”, “2024 Listed Companies with Excellent Practices for High Quality Development Honors such as “Excellent Example of Innovation and Development” and “2024 Capital Power Annual Selection 'Excellent Brand Award'”.